T2 Biosystems Inc. (TTOO)
Symbol Info
Listed Symbol TTOO
Name T2 Biosystems Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $10,500,000
Latest Fiscal EPS $-1.28
Price Info
21 Day Moving Average $1.4723
21 Day EMA $1.670440
50 Day Moving Average $1.3478
50 Day EMA $1.530990
200 Day EMA $2.621580
200 Day Moving Average 2.596200
52 Week High $7.70
52 Week Low $0.52
52 Week Change $-54.645700
Alpha -0.004818
Beta 1.3944
Standard Deviation 0.296392
R2 0.026306
Periods 60
Share Information
10 Day Average Volume 4,117,873
20 Day Average Volume 2,674,998
30 Day Average Volume 3,029,776
50 Day Average Volume 2,302,555
Outstanding Shares 44,535,572
Float Shares 43,402,765
Percent Float 97.46%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 163
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 1,058,282
Institute Holdings Percent 45.600000
Institute Sold Previous 3 Months 4,813,145
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,132,807
Price Change
7 Day Price Change $1.4900001
7 Day Percent Change 107.19%
21 Day Price Change $1.6900000
21 Day Percent Change 142.02%
30 Day Price Change $2.0699000
30 Day Percent Change 255.51%
Month To Date Price Change $1.5500
Month To Date Percent 116.54%
90 Day Price Change $0.990000
90 Day Percent Change 52.38%
Quarter To Date $1.200000
Quarter To Date Percent 71.43%
180 Day Price Change $0.260000
180 Day Percent Change 9.92%
200 Day Price Change $-1.1
200 Day Percent Change -27.64%
Year To Date $-0.13
Year To Date Percent -4.32%
Profile
Description T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. Its core technology is the T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.
Details
Issue Type CS
Market Cap $128,262,447
Sec Type EQS
Auditor BDO USA, LLP
Total Shares Outstanding 44,535,572
CEO
Employees 153
Last Audit UE
Classification
CIK 0001492674
Industry Medical Diagnostics & Research
Sector Healthcare
NAICS In-Vitro Diagnostic Substance Manufacturing(325413)
Info
Address 101 Hartwell Avenue
Lexington, MA 2421
Website http://www.t2biosystems.com
Facisimile +1 781 357-3080
Telephone +1 781 761-4646
Email ir@T2Biosystems.com
Key Ratios
Profitability
EBIT Margin -628.5
EBITDA Margin -589.1
Pre-Tax Profit Margin -6,231.3
Profit Margin Cont -
Gross Margin -127.9
Profit Margin TOT -
Income Statements
Revenue $7,059,000
Revenue Per Share $0.1585
Revenue 3 Years $27.92
Revenue 5 Years $123.54
Valuation Measures
PE Ratio -
Enterprise Value $81,549,800
Price To Sales 18.170061
Price To Free Cash -1.5
PE High Last 5 Years -
Price To Book 10.0
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book -4
Financial Strength
Total Debt To Equity -
Int Coverage -6.7
Current Ratio 0.6
Leverage Ratio 13.8
Quick Ratio 0.5
Long Term Debt To Capital -
Assets
Receivables Turnover 8.8
Invoice Turnover 6.90
Assets Turnover 0.10
Management Effectiveness
Return Assets -89.12
Return On Equity -729.05
Return On Capital -92.97
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type
Your Recent History
NASDAQ
TTOO
T2 Biosyst..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20190915 10:19:23